On December 19, 2023, Hasten’s CEO Summer XIA, Vice President and Head of Commercial Excellence Hanson Zheng and other senior leaders from Hasten visited Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun), and signed a MOU for the deep collaboration with CR Gosun.
On December 14, 2023, Hasten Biopharmaceutical Co., Ltd announced that it will enter into a strategic business partnership with Apeloa Pharmaceutical Co., Ltd.
December 8th, 2023 – Shanghai, China. Avon Group, a leading global professional services firm, today announced it has released the China Best ESG Employers Award list for 2023 and another eight earning individual awards for outstanding performance in their specific fields. Hasten Biopharmaceutical Company Limited (Hasten) was awarded " 2023 China's Best Employer ESG Seed Award" for the energy and great potential of company’s organizational optimization and agile operation model.
Hasten Biopharmaceutical Co., Ltd. (Hasten) and China Resources Pharmaceutical Commercial Group (Shanghai) Co., Ltd. reached a strategic cooperation at the 6th CIIE on November 7th of 2023.
-- Hasten obtains rights to develop and commercialize lerodalcibep in Chinese Mainland, Hong Kong, Macau, and Taiwan and will be responsible for clinical development and regulatory approval in these territories
On July 11th, the "2023 Beijing International Life and Health Industry Cross-border Expo, Life and Health Innovators Annual Conference" was officially opened at the China International Exhibition Center in Beijing. With the theme of "4D Rules of Innovation Track", the branch ceremony, “Life and Health Innovators Annual Conference" organized by SiqiQuan, was launched there simultaneously.